Hepatotoxicity was reported in a case characterized by a 10-fold increase in aminotransferase and alanine aminotransferase activities after two doses of hydroxychloroquine for treatment of COVID-19 (Falcao, Cavalcanti et al., 2020), but enzyme activities returned to normal after drug discontinuation. The gene discussed is GPT; the disease is COVID-19.